Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Nov 3, 2026
- Incorporated
- Delaware
- Filings on record
- 789 filings
- On EDGAR
- CIK 1714899
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 38
News 8 of 102
- 8-K Quarterly results Nov 3, 2026
- 8-K Quarterly results Aug 6, 2026
- 8-K Acquisition or disposal closed Jul 28, 2026
- 8-K Significant contract Jun 18, 2026
- 8-K Shareholder vote results Jun 4, 2026
- 8-K Current report on a material event May 22, 2026
- 8-K Quarterly results May 7, 2026
- 8-K Current report on a material event Apr 3, 2026
Prospectuses and Registrations 8 of 23
- S-8 Registration statement for an employee plan Feb 26, 2026
- 424B5 Prospectus supplement for an offering Dec 10, 2025
- 424B5 Prospectus supplement for an offering Dec 9, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
- S-3ASR Automatic shelf registration Feb 27, 2025
- S-3ASR Automatic shelf registration Mar 22, 2024
- S-8 Registration statement for an employee plan Feb 28, 2024
- S-8 Registration statement for an employee plan Feb 27, 2023
Proxies 8 of 18
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 17, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2025
- DEFA14A Extra proxy material Apr 18, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2024
- DEFA14A Extra proxy material Apr 18, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2023
Ownership 8 of 578
- 4 Insider reported a trade Sep 9, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 4 Insider reported a trade Sep 4, 2026
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 13, 2026
Other 8 of 30
- ARS Annual report sent to shareholders Apr 21, 2026
- ARS Annual report sent to shareholders Apr 17, 2025
- ARS Annual report sent to shareholders Apr 18, 2024
- D Mar 1, 2024
- ARS Annual report sent to shareholders Apr 18, 2023
- UPLOAD Comment letter from SEC staff Oct 7, 2019
- CORRESP Reply to SEC staff Sep 11, 2019
- UPLOAD Comment letter from SEC staff Aug 16, 2019
Everything here comes from Denali Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.